For the systemic inflammation, increased interleukin-8 in vitro [47], elevated pro-inflammatory cytokine interleukin-6 [48], leukotriene E4 and prostacyclin in vivo [44] were involved in the biologic effects of iAs on ASCVD risk. Here, CXCL8 is linked to atherosclerosis.